The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
about
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I MetabolitesZNF32 inhibits autophagy through the mTOR pathway and protects MCF-7 cells from stimulus-induced cell death.The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.Targeting cancer by binding iron: Dissecting cellular signaling pathwaysA novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIα.Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomibThe novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivoTargeting autophagy in antitumor agent design: furthering the 'lysosomal love' strategy.Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics.Combination of Fe/Cu -chelators and docosahexaenoic acid: an exploration for the treatment of colorectal cancer.IRON METABOLISM AND AUTOPHAGY: A POORLY EXPLORED RELATIONSHIP THAT HAS IMPORTANT CONSEQUENCES FOR HEALTH AND DISEASE.Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
P2860
Q28550205-0838FA9F-74E2-4BE9-BA03-99787B851EECQ35193672-077039AB-67EA-428E-9B98-3E21594712B2Q35832242-A26E14C4-B8E8-461C-A010-42C98FA7B692Q36326247-6CD4F1E9-3AB4-4CDC-8CA7-1FEB748DA430Q36440601-B2FAD4ED-372E-4022-BFBE-D1EB1391D0A4Q36782473-51686DDA-43B3-4BF0-8543-A4DDDD1AEC6CQ37291716-5AC334BC-348A-460C-813D-CC0647F2C6ECQ37553760-AA5B6DDD-80B2-473F-827D-311A4B116C65Q38871101-6683E3C0-0FC0-4A26-8ED4-221B56EBD1D0Q38873926-A2693298-A878-4861-A0A6-FD90CCF74207Q41612844-8BD9A9EF-91CB-41AC-B50E-E9898F01C370Q43188281-D45973B4-1395-4617-9D55-FC9D5624226AQ45324502-0D367D68-B3BE-4D52-9604-5AA47CE47171
P2860
The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@ast
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@en
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@nl
type
label
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@ast
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@en
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@nl
prefLabel
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@ast
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@en
The anticancer agent di-2-pyri ...... irment of lysosomal integrity.
@nl
P2860
P356
P1476
The anticancer agent di-2-pyri ...... airment of lysosomal integrity
@en
P2093
Elaine Gutierrez
Patric J Jansson
P2860
P304
33568-33589
P356
10.1074/JBC.M114.599480
P407
P577
2014-10-09T00:00:00Z